Holen Sie sich die Stockscreener-App
13.85
6.73%
-1.00
Schlusskurs vom Vortag:
$14.85
Offen:
$14.9
24-Stunden-Volumen:
49,864
Relative Volume:
0.96
Marktkapitalisierung:
$97.27M
Einnahmen:
$100.44M
Nettoeinkommen (Verlust:
$-133.16M
KGV:
-0.5377
EPS:
-25.76
Netto-Cashflow:
$-94.85M
1W Leistung:
-11.16%
1M Leistung:
-3.89%
6M Leistung:
+77.11%
1J Leistung:
+42.64%
1-Tages-Spanne:
$13.70
$15.30
1-Wochen-Bereich:
$13.30
$15.74
52-Wochen-Spanne:
$5.005
$18.70
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
Firmenname
Atara Biotherapeutics Inc
Sektor
Branche
Telefon
805-623-4211
Adresse
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Vergleichen Sie ATRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
13.85 | 104.29M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-07-20 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-07-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-13 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-05-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Eingeleitet | Evercore ISI | Outperform |
| 2020-06-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-09-27 | Herabstufung | Goldman | Neutral → Sell |
| 2019-09-16 | Herabstufung | Jefferies | Buy → Hold |
| 2019-06-04 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-05-23 | Eingeleitet | Stifel | Buy |
| 2019-01-23 | Eingeleitet | Mizuho | Buy |
| 2018-04-10 | Eingeleitet | JP Morgan | Overweight |
| 2018-03-16 | Eingeleitet | Guggenheim | Neutral |
| 2018-03-05 | Bestätigt | Jefferies | Buy |
| 2018-02-28 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-01-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-10-06 | Fortgesetzt | Goldman | Neutral |
Alle ansehen
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
Atara Biotherapeutics (ATRA) Transfers Key FDA Application to Pi - GuruFocus
Pierre Fabre takes over tabelecleucel BLA from Atara Biotherapeutics - Investing.com
Atara (NASDAQ: ATRA) transfers tabelecleucel BLA to Pierre Fabre; PDUFA Jan 10, 2026 - Stock Titan
Can machine learning forecast Atara Biotherapeutics Inc. recoveryJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Will Atara Biotherapeutics Inc. stock attract ESG investorsJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
Can Atara Biotherapeutics Inc. stock deliver sustainable ROEQuarterly Profit Report & Real-Time Volume Analysis Alerts - newser.com
Is Atara Biotherapeutics Inc. (AT20) stock trading at attractive multiplesQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Is Atara Biotherapeutics Inc. (AT20) stock nearing a technical breakoutProfit Target & Fast Exit/Entry Strategy Plans - newser.com
How to recover losses in Atara Biotherapeutics Inc. stockDay Trade & Weekly Breakout Watchlists - newser.com
Will Atara Biotherapeutics Inc. (AT20) stock beat value stocks2025 Buyback Activity & Fast Gain Stock Trading Tips - newser.com
Live market analysis of Atara Biotherapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - newser.com
Will Atara Biotherapeutics Inc. (AT20) stock sustain uptrend momentumMarket Volume Report & Capital Efficient Trade Techniques - newser.com
Will Atara Biotherapeutics Inc. stock maintain growth storyQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Will a bounce in Atara Biotherapeutics Inc. offer an exitWall Street Watch & Expert Verified Stock Movement Alerts - newser.com
How robust is Atara Biotherapeutics Inc. (AT20) stock financial positionJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Custom strategy builders for tracking Atara Biotherapeutics Inc.Trade Analysis Report & Fast Gain Stock Trading Tips - newser.com
How hedge fund analytics apply to Atara Biotherapeutics Inc. stockNew Guidance & Verified Momentum Stock Watchlist - newser.com
Is Atara Biotherapeutics Inc. stock supported by strong fundamentals2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
How Atara Biotherapeutics Inc. (AT20) stock performs during market turbulenceJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Is Atara Biotherapeutics Inc. forming a bottoming baseMarket Trend Review & Reliable Volume Spike Alerts - newser.com
Institutional scanner results for Atara Biotherapeutics Inc.July 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
5 Under-the-Radar Biotech Stocks That Could Soar in 2026 - Barchart.com
Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):